3-Chloro-5-(2,2,2-trifluoroethoxy)pyridazine, 95.0%, 10g

N-Ethyl-4-nitrobenzenesulfonamide, 95.0%, 1g

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indole-1-carboxylate, 95.0%, 5g

N-Ethyl-4-hydroxypiperidine, 95.0%, 1g

6-Bromo-2,3-dihydrobenzofuran, 95.0%, 250mg

(1R,4S)-4-((tert-Butoxycarbonyl)amino)cyclopent-2-enecarboxylic acid, 95.0%, 250mg

2-Amino-3-iodo-5-bromopyridine, 97.0%, 1g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 150, 6000 ml, 190 mm, 1 Piece

5-Amino-1-(3-methylphenyl)-1H-1,2,3-triazole-4-carboxamide, 95.0%, 250mg

3-(7-Bromo-9,9-dimethyl-9H-fluoren-2-yl)-9-phenyl-9H-carbazole, 98%, 250mg

5-oxo-5-(4-n-pentylphenyl)valeric acid, 97.0%, 2g

1-methyl-6-oxopiperidine-3-carboxylic acid, 95.0%, 250mg

Methyl 5-bromo-2-naphthoate, 98.0%, 1g